Olof Tyden
Director
Pharmaceutical sciences
Oncopeptides AB (ONCO.ST)
Sweden
Biography
Olof Tyden has been Independent Director at Oncopeptides AB since 2014. Olof is a Partner at Eureda, an international pharmaceutical consulting firm. Olof has previously held positions as Medical Director at Leo Pharmaceuticals and Kabi-Vitrum (now Pfizer) and Program Director at the Medical Products Agency in Sweden. Olaf was for six years Senior Regulatory Adviser at Hoffman-La Roche with responsibility for EU strategies, knowledge management and training. In 2000 he founded Eureda, a strategic regulatory consultancy. Olof has also served as an expert to the European Commission in Health Telematics and has been a member of the board of life sciences companies Bioxell SpA, Aprea AB, Cantargia AB and Ximmune AB. Olof holds a Ph.D. from Uppsala University and an associate professorship in obstetrics and gynecology at Uppsala University. He is Director of Eureda AB and Alternate Director of Uppsala Medical Information AB.
Research Interest
pharmaceutical sciences business and administration
